Cite

HARVARD Citation

    Grimm, W. et al. (2016). The Thr300Ala variant in ATG16L1 is associated with improved survival in human colorectal cancer and enhanced production of type I interferon. Gut. 65 (3), pp. 456-464. [Online]. 
  
Back to record